Elliot Wilbur

Stock Analyst at Raymond James

(1.92)
# 3,210
Out of 5,033 analysts
55
Total ratings
33.33%
Success rate
5.34%
Average return

Stocks Rated by Elliot Wilbur

ADMA Biologics
May 8, 2025
Maintains: Strong Buy
Price Target: $25$32
Current: $14.36
Upside: +122.84%
ANI Pharmaceuticals
Sep 18, 2024
Maintains: Outperform
Price Target: $81$83
Current: $94.79
Upside: -12.44%
Sol-Gel Technologies
Aug 19, 2024
Downgrades: Outperform
Price Target: $60$40
Current: $40.60
Upside: -1.48%
Organon & Co.
Mar 16, 2023
Initiates: Outperform
Price Target: $33
Current: $9.28
Upside: +255.60%
Perrigo Company
Mar 6, 2023
Maintains: Outperform
Price Target: $42$43
Current: $21.62
Upside: +98.89%
PolyPid
Sep 6, 2022
Downgrades: Outperform
Price Target: $450$120
Current: $3.27
Upside: +3,569.72%
Viatris
Mar 1, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $10.17
Upside: -
Teva Pharmaceutical Industries
Oct 28, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $19.31
Upside: -
Zoetis
Jul 16, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $144.06
Upside: -
Elanco Animal Health
Jan 10, 2020
Initiates: Market Perform
Price Target: n/a
Current: $21.42
Upside: -
Upgrades: Market Perform
Price Target: n/a
Current: $7.17
Upside: -
Downgrades: Market Perform
Price Target: n/a
Current: $23.78
Upside: -